Infectious DiseaseInfectious DiseaseMost recent genetic diagnosis by using PCR and next-generation sequencing (NGS) has significantly improved the understanding of molecular mechanism of hematological malignancies, leading to the right choice of molecular targeting drugs for precision therapy for the individual patients in clinic. To help precise medicine in hematological malignancies such as leukemia, lymphoma, and multiple myeloma, MEDx has developed a variety of blood cancer tests containing panel gene assays and single target tests applied to the diagnosis and treatment of hematological proliferative disorders, and to the monitoring of recurrence and drug resistance of hematological malignancies.
- About MEDx
- Technology Centers
- Pharma Solutions
-
CDx/IVD Products
IHC-Based AssaysPCR-Based AssaysNGS-Based AssaysMore AssaysCustomized Assays - Clinical Testing
- Quality Systems
- Events
- Contact Us
Home / Clinical Testing / Infectious Disease
Infectious Disease
Coming soon...
If you have any of the following needs, feel free to contact us or email us at inquiry@MEDxTMC.net . We will reply within 24 hours.
1. Customized or bulk orders of IVD/CDx products.
2. Get a quote for IVD/CDx products
3. Become our distributor
4. Get customized pharmaceutical service solutions
5.Learn more about our technology and R&D
Follow MEDx
